NCT04587791View on ClinicalTrials.gov

Cannabidiol in Opioid Use Disorder and Chronic Pain

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

March 31, 2026

Conditions
Chronic PainOpioid Use Disorder
Interventions
DRUG

400mg Cannabidiol

Participants will receive 400mg

DRUG

800mg Cannabidiol

Participants will receive 800mg

DRUG

1200mg Cannabidiol

Participants will receive 1200mg

DRUG

Saline

Participants will receive saline

Trial Locations (1)

06516

RECRUITING

Department of Veterans Affairs Hospital, West Haven

All Listed Sponsors
collaborator

VA Connecticut Healthcare System

FED

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER